This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Orkambi - Lumacaftor with Ivacaftor

Vertex

Description

Lumacaftor increases the number of proteins that each the cell surface. Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) protein potentiator that increases chloride transport in the abnormal CFTR protein.

By mouth using granules
Child 2–5 years (body-weight up to 14 kg): 100/125 mg every 12 hours.
Child 2–5 years (body-weight 14 kg and above): 150/188 mg every 12 hours.

By mouth using tablets
Child 6–11 years: 200/250 mg every 12 hours.
Child 12–17 years: 400/250 mg every 12 hours.
Adult: 400/250 mg every 12 hours – specialist use only.

Indications

Lumacaftor increases the number of proteins that each the cell surface. Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) protein potentiator that increases chloride transport in the abnormal CFTR protein.

Contraindications

Use with caution in the case of hepatic impairment. 

Preparations Available

Tablets

Sizes Available

Tablets
Orkambi 100 mg/125 mg, 112 tablets
Orkambi 200 mg/125 mg, 112 tablets

Granules
Orkambi 100 mg/125 mg, 56 sachets
Orkambi 150 mg/188 mg, 56 sachets

More on: Mucolytics , Lumacaftor with Ivacaftor